In Vitro Selection of Specific DNA Aptamers Against the Anti-Coagulant Dabigatran Etexilate
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Selection of Specific DNA Aptamers Against the Anti-Coagulant Dabigatran Etexilate
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-30
DOI
10.1038/s41598-018-31327-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small-Molecule Binding Aptamers: Selection Strategies, Characterization, and Applications
- (2016) Annamaria Ruscito et al. Frontiers in Chemistry
- Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations
- (2016) Mojca Božič-Mijovski et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Aptamer-Based Label-Free Impedimetric Biosensor for Detection of Progesterone
- (2015) Gastón Contreras Jiménez et al. ANALYTICAL CHEMISTRY
- DNA aptamers selection and characterization for development of label-free impedimetric aptasensor for neurotoxin anatoxin-a
- (2015) Reda Elshafey et al. BIOSENSORS & BIOELECTRONICS
- Epidemiology of venous thromboembolism
- (2015) John A. Heit Nature Reviews Cardiology
- Generation of an anti-Dabigatran Monoclonal Antibody and Its Use in a Highly Sensitive and Specific Enzyme-Linked Immunosorbent Assay for Serum Dabigatran
- (2015) Shigeru Oiso et al. THERAPEUTIC DRUG MONITORING
- Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants
- (2015) Charles V. Pollack et al. THROMBOSIS AND HAEMOSTASIS
- UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays
- (2015) Joachim Kuhn et al. PLoS One
- New Anticoagulants and Antiplatelet Agents: A Primer for the Clinical Gastroenterologist
- (2014) Parth J Parekh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Thrombosis
- (2014) G.E. Raskob et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants
- (2014) E. M. H. Schmitz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran, bleeding, and the regulators
- (2014) T. J. Moore et al. BMJ-British Medical Journal
- A specific antidote for dabigatran: functional and structural characterization
- (2013) F. Schiele et al. BLOOD
- The Discovery of Dabigatran Etexilate
- (2013) Joanne van Ryn et al. Frontiers in Pharmacology
- Dabigatran Effects on the International Normalized Ratio, Activated Partial Thromboplastin Time, Thrombin Time, and Fibrinogen: A Multicenter, In Vitro Study
- (2012) William E Dager et al. ANNALS OF PHARMACOTHERAPY
- Primary and Secondary Prevention of Cardiovascular Disease
- (2012) Per Olav Vandvik et al. CHEST
- Aptamers and the next generation of diagnostic reagents
- (2012) Varatharasa Thiviyanathan et al. Proteomics Clinical Applications
- Aptamers and Their Biological Applications
- (2012) Kyung-Mi Song et al. SENSORS
- Direct thrombin inhibitors
- (2011) Catherine J. Lee et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Anticoagulating obese patients in the modern era
- (2011) Jignesh P. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons
- (2011) X. Ni et al. CURRENT MEDICINAL CHEMISTRY
- Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures
- (2011) Abhijit Rangnekar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor
- (2009) Joachim Stangier et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started